ECKERT & ZIEGLER SE (EUZ.DE) Stock Fundamental Analysis
Europe - FRA:EUZ - DE0005659700 - Common Stock
17.17 EUR
+0.06 (+0.35%)
Overall EUZ gets a fundamental rating of 7 out of 10. We evaluated EUZ against 59 industry peers in the Health Care Equipment & Supplies industry. EUZ has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. EUZ is not valued too expensively and it also shows a decent growth rate. These ratings would make EUZ suitable for quality investing!
1. Profitability
1.1 Basic Checks
In the past year EUZ was profitable.
In the past year EUZ had a positive cash flow from operations.
In the past 5 years EUZ has always been profitable.
In the past 5 years EUZ always reported a positive cash flow from operatings.
1.2 Ratios
EUZ's Return On Assets of 8.35% is amongst the best of the industry. EUZ outperforms 81.36% of its industry peers.
With an excellent Return On Equity value of 16.32%, EUZ belongs to the best of the industry, outperforming 81.36% of the companies in the same industry.
The Return On Invested Capital of EUZ (12.73%) is better than 89.83% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EUZ is in line with the industry average of 8.92%.
The last Return On Invested Capital (12.73%) for EUZ is above the 3 year average (9.92%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.35% | ||
| ROE | 16.32% | ||
| ROIC | 12.73% |
ROA(3y)6.9%
ROA(5y)7.6%
ROE(3y)13.51%
ROE(5y)14.72%
ROIC(3y)9.92%
ROIC(5y)9.15%
1.3 Margins
EUZ's Profit Margin of 12.24% is fine compared to the rest of the industry. EUZ outperforms 72.88% of its industry peers.
EUZ's Profit Margin has declined in the last couple of years.
EUZ has a better Operating Margin (21.68%) than 84.75% of its industry peers.
EUZ's Operating Margin has improved in the last couple of years.
The Gross Margin of EUZ (47.96%) is worse than 61.02% of its industry peers.
EUZ's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.68% | ||
| PM (TTM) | 12.24% | ||
| GM | 47.96% |
OM growth 3Y9.05%
OM growth 5Y5.71%
PM growth 3Y-16.23%
PM growth 5Y-1.83%
GM growth 3Y-1.4%
GM growth 5Y-0.15%
2. Health
2.1 Basic Checks
EUZ has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for EUZ remains at a similar level compared to 1 year ago.
EUZ has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, EUZ has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 5.10 indicates that EUZ is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.10, EUZ belongs to the top of the industry, outperforming 84.75% of the companies in the same industry.
EUZ has a debt to FCF ratio of 0.86. This is a very positive value and a sign of high solvency as it would only need 0.86 years to pay back of all of its debts.
The Debt to FCF ratio of EUZ (0.86) is better than 88.14% of its industry peers.
EUZ has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of EUZ (0.18) is better than 69.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 0.86 | ||
| Altman-Z | 5.1 |
ROIC/WACC1.82
WACC6.99%
2.3 Liquidity
A Current Ratio of 3.04 indicates that EUZ has no problem at all paying its short term obligations.
The Current ratio of EUZ (3.04) is better than 81.36% of its industry peers.
A Quick Ratio of 3.00 indicates that EUZ has no problem at all paying its short term obligations.
The Quick ratio of EUZ (3.00) is better than 89.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.04 | ||
| Quick Ratio | 3 |
3. Growth
3.1 Past
EUZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.02%, which is quite good.
Measured over the past years, EUZ shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.65% on average per year.
EUZ shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.42%.
Measured over the past years, EUZ shows a quite strong growth in Revenue. The Revenue has been growing by 10.63% on average per year.
EPS 1Y (TTM)16.02%
EPS 3Y-1.23%
EPS 5Y8.65%
EPS Q2Q%24.4%
Revenue 1Y (TTM)9.42%
Revenue growth 3Y17.92%
Revenue growth 5Y10.63%
Sales Q2Q%3.66%
3.2 Future
The Earnings Per Share is expected to grow by 17.96% on average over the next years. This is quite good.
EUZ is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.27% yearly.
EPS Next Y33.97%
EPS Next 2Y21.92%
EPS Next 3Y17.96%
EPS Next 5YN/A
Revenue Next Year8.76%
Revenue Next 2Y8.03%
Revenue Next 3Y8.27%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 29.10 indicates a quite expensive valuation of EUZ.
66.10% of the companies in the same industry are more expensive than EUZ, based on the Price/Earnings ratio.
EUZ's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.30.
A Price/Forward Earnings ratio of 18.65 indicates a rather expensive valuation of EUZ.
Based on the Price/Forward Earnings ratio, EUZ is valued a bit cheaper than 72.88% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of EUZ to the average of the S&P500 Index (22.73), we can say EUZ is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.1 | ||
| Fwd PE | 18.65 |
4.2 Price Multiples
EUZ's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. EUZ is cheaper than 79.66% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, EUZ is valued cheaper than 83.05% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.21 | ||
| EV/EBITDA | 12.07 |
4.3 Compensation for Growth
EUZ's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EUZ has a very decent profitability rating, which may justify a higher PE ratio.
EUZ's earnings are expected to grow with 17.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.86
PEG (5Y)3.36
EPS Next 2Y21.92%
EPS Next 3Y17.96%
5. Dividend
5.1 Amount
EUZ has a yearly dividend return of 0.97%, which is pretty low.
The stock price of EUZ dropped by -47.45% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
EUZ's Dividend Yield is a higher than the industry average which is at 2.30.
With a Dividend Yield of 0.97, EUZ pays less dividend than the S&P500 average, which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.97% |
5.2 History
The dividend of EUZ decreases each year by -43.97%.
Dividend Growth(5Y)-43.97%
Div Incr Years1
Div Non Decr Years3
5.3 Sustainability
EUZ pays out 31.30% of its income as dividend. This is a sustainable payout ratio.
DP31.3%
EPS Next 2Y21.92%
EPS Next 3Y17.96%
FRA:EUZ (9/12/2025, 7:00:00 PM)
17.17
+0.06 (+0.35%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners25.96%
Inst Owner ChangeN/A
Ins Owners0.23%
Ins Owner ChangeN/A
Market Cap1.09B
Analysts80
Price Target22.9 (33.37%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.97% |
Yearly Dividend0.02
Dividend Growth(5Y)-43.97%
DP31.3%
Div Incr Years1
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-66.76%
PT rev (3m)-66.76%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-64.28%
EPS NY rev (3m)-64.28%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.59%
Revenue NY rev (3m)-0.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.1 | ||
| Fwd PE | 18.65 | ||
| P/S | 3.64 | ||
| P/FCF | 19.21 | ||
| P/OCF | 14.56 | ||
| P/B | 4.86 | ||
| P/tB | 6.12 | ||
| EV/EBITDA | 12.07 |
EPS(TTM)0.59
EY3.44%
EPS(NY)0.92
Fwd EY5.36%
FCF(TTM)0.89
FCFY5.2%
OCF(TTM)1.18
OCFY6.87%
SpS4.71
BVpS3.54
TBVpS2.8
PEG (NY)0.86
PEG (5Y)3.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.35% | ||
| ROE | 16.32% | ||
| ROCE | 17.92% | ||
| ROIC | 12.73% | ||
| ROICexc | 18.45% | ||
| ROICexgc | 22.68% | ||
| OM | 21.68% | ||
| PM (TTM) | 12.24% | ||
| GM | 47.96% | ||
| FCFM | 18.97% |
ROA(3y)6.9%
ROA(5y)7.6%
ROE(3y)13.51%
ROE(5y)14.72%
ROIC(3y)9.92%
ROIC(5y)9.15%
ROICexc(3y)13.44%
ROICexc(5y)13%
ROICexgc(3y)17.78%
ROICexgc(5y)17.59%
ROCE(3y)13.96%
ROCE(5y)12.89%
ROICexcg growth 3Y11.22%
ROICexcg growth 5Y1.55%
ROICexc growth 3Y17.53%
ROICexc growth 5Y5.68%
OM growth 3Y9.05%
OM growth 5Y5.71%
PM growth 3Y-16.23%
PM growth 5Y-1.83%
GM growth 3Y-1.4%
GM growth 5Y-0.15%
F-Score7
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 0.86 | ||
| Debt/EBITDA | 0.47 | ||
| Cap/Depr | 89.91% | ||
| Cap/Sales | 6.07% | ||
| Interest Coverage | 77.32 | ||
| Cash Conversion | 88.08% | ||
| Profit Quality | 154.92% | ||
| Current Ratio | 3.04 | ||
| Quick Ratio | 3 | ||
| Altman-Z | 5.1 |
F-Score7
WACC6.99%
ROIC/WACC1.82
Cap/Depr(3y)190.39%
Cap/Depr(5y)187.58%
Cap/Sales(3y)10.17%
Cap/Sales(5y)10.1%
Profit Quality(3y)67.54%
Profit Quality(5y)69.62%
High Growth Momentum
Growth
EPS 1Y (TTM)16.02%
EPS 3Y-1.23%
EPS 5Y8.65%
EPS Q2Q%24.4%
EPS Next Y33.97%
EPS Next 2Y21.92%
EPS Next 3Y17.96%
EPS Next 5YN/A
Revenue 1Y (TTM)9.42%
Revenue growth 3Y17.92%
Revenue growth 5Y10.63%
Sales Q2Q%3.66%
Revenue Next Year8.76%
Revenue Next 2Y8.03%
Revenue Next 3Y8.27%
Revenue Next 5YN/A
EBIT growth 1Y12.09%
EBIT growth 3Y28.59%
EBIT growth 5Y16.95%
EBIT Next Year57.03%
EBIT Next 3Y19.41%
EBIT Next 5YN/A
FCF growth 1Y272.16%
FCF growth 3Y114.55%
FCF growth 5Y8.28%
OCF growth 1Y70.09%
OCF growth 3Y25.28%
OCF growth 5Y10.49%